
    
      Eyes from 80 patients will be randomized in a 1:1 ratio to the assigned treatment,
      dexamethasone insert placed at the time of surgery, or topical prednisolone acetate 1%
      therapy prescribed on a tapering dose schedule post-operatively.

      Males and Females 18 years and older with 1)Presence of a visually significant cataract with
      plans to undergo clear cornea cataract surgery with phacoemulsification and implantation of a
      posterior chamber intraocular lens (IOL), and potential postoperative Snellen pinhole
      corrected distance visual acuity (CDVA) of at least 20/200 in both eyes and 2) 10 patients
      with mild-to-moderate primary open angle glaucoma and a visually significant cataract with
      plans to undergo clear cornea cataract surgery with phacoemulsification and implantation of a
      posterior chamber Intraocular Len (IOL) combined with a Minimally Invasive Glaucoma Surgery
      (MIGS) procedure in both eyes.

      Study visits will consist of eye exam with ocular photos from an Optical Coherence Tomography
      (OCT).
    
  